DEVELOPMENT OF A YERSINIA RUCKERI O1 BIOTYPE 2 WATERBORNE CHALLENGE MODEL FOR FUTURE ERM VACCINE TESTING IN RAINBOW TROUT

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Standard

DEVELOPMENT OF A YERSINIA RUCKERI O1 BIOTYPE 2 WATERBORNE CHALLENGE MODEL FOR FUTURE ERM VACCINE TESTING IN RAINBOW TROUT. / Kragelund Strøm, Helene; Aalbæk, Bent; Otani, Maki; Villumsen, Kasper Rømer; Neumann, Lukas; Raida, Martin Kristian.

In: Fish and Shellfish Immunology, Vol. 34, No. 6, 2013, p. 1739.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Harvard

Kragelund Strøm, H, Aalbæk, B, Otani, M, Villumsen, KR, Neumann, L & Raida, MK 2013, 'DEVELOPMENT OF A YERSINIA RUCKERI O1 BIOTYPE 2 WATERBORNE CHALLENGE MODEL FOR FUTURE ERM VACCINE TESTING IN RAINBOW TROUT', Fish and Shellfish Immunology, vol. 34, no. 6, pp. 1739. https://doi.org/10.1016/j.fsi.2013.03.317

APA

Kragelund Strøm, H., Aalbæk, B., Otani, M., Villumsen, K. R., Neumann, L., & Raida, M. K. (2013). DEVELOPMENT OF A YERSINIA RUCKERI O1 BIOTYPE 2 WATERBORNE CHALLENGE MODEL FOR FUTURE ERM VACCINE TESTING IN RAINBOW TROUT. Fish and Shellfish Immunology, 34(6), 1739. https://doi.org/10.1016/j.fsi.2013.03.317

Vancouver

Kragelund Strøm H, Aalbæk B, Otani M, Villumsen KR, Neumann L, Raida MK. DEVELOPMENT OF A YERSINIA RUCKERI O1 BIOTYPE 2 WATERBORNE CHALLENGE MODEL FOR FUTURE ERM VACCINE TESTING IN RAINBOW TROUT. Fish and Shellfish Immunology. 2013;34(6):1739. https://doi.org/10.1016/j.fsi.2013.03.317

Author

Kragelund Strøm, Helene ; Aalbæk, Bent ; Otani, Maki ; Villumsen, Kasper Rømer ; Neumann, Lukas ; Raida, Martin Kristian. / DEVELOPMENT OF A YERSINIA RUCKERI O1 BIOTYPE 2 WATERBORNE CHALLENGE MODEL FOR FUTURE ERM VACCINE TESTING IN RAINBOW TROUT. In: Fish and Shellfish Immunology. 2013 ; Vol. 34, No. 6. pp. 1739.

Bibtex

@article{a3612d06d520482db938fe4cbf4589bd,
title = "DEVELOPMENT OF A YERSINIA RUCKERI O1 BIOTYPE 2 WATERBORNE CHALLENGE MODEL FOR FUTURE ERM VACCINE TESTING IN RAINBOW TROUT",
abstract = "Yersinia ruckeri (Y.r.) O1 biotype (bt) 2 causes outbreaks of Enteric Redmouth disease (ERM) in vaccinated, farmed rainbow trout around the world. Y.r. O1 bt 1 has been known since first described from the Hagerman Valley in Idaho in the 1950{\textquoteright}s and outbreaks have now been controlled by vaccination for more than 35 years. Recent years have shown ERM outbreaks caused by Y.r. O1 bt 2 reported from ERM vaccinated farmed rainbow trout stocks in both Europe and the USA. It has been suggested that Y.r. O1 bt 2 is more virulent than bt 1. In order to test this hypothesis we have collected Y.r. O1 isolates from ERM outbreaks in Danish rainbow trout farms during 2011. Some of the isolates were obtained from vaccinated stocks, which subsequently developed ERM disease outbreaks. The Y.r. O1 isolates have been characterized and biotyped according to mobility and hydrolysis of Tween-80, and almost all isolates obtained in 2011 were double negative, which characterizes them as bt 2. Only one Y.r. O1 bt 1 strain was isolated, the rest of all the Y.r. O1 strains belonged to bt 2. Y.r. O1 bt 1 has been isolated from Danish rainbow trout farms for 30 years, but Y.r. O1 bt 2 has first been detected 12 years later and has caused many outbreaks of ERM which has led to an increase in the use of antibiotics. In order to determine the virulence of the newly isolated Y.r. O1 strains, experimental infections were carried out. The mortalities of the newly isolated strains were compared to well characterized isolates of both bt 1 and 2. In order to mimic a natural Y.r. infection, a bath infection model was applied. All Y.r. O1 isolates caused significant mortality compared to the un-infected control group. The Y.r. O1 isolates could be divided into two groups, regarding their virulence: A low virulence group causing less than 50 % mortality, and a high virulence group causing more than 50 % mortality. Interestingly, all tested bt 1 isolates grouped in the low virulence group together with a few bt 2 isolates. The highly virulent strains were exclusively Y.r. O1 bt 2 strains. The most virulent strain was obtained from a population of rainbow trout which had been immersion vaccinated with a commercial vaccine containing a bacterin of both Y.r. O1 bt 1 and 2 and received an oral booster vaccination 4 month later as recommended by the manufacturer. The characterization of this highly virulent strain of Y.r. O1 bt 2 has made it possible to develop a standardized bath challenge model which is needed in order to test and develop new experimental vaccines which are expected to induce immunity against Y.r. O1 bt 2.",
author = "{Kragelund Str{\o}m}, Helene and Bent Aalb{\ae}k and Maki Otani and Villumsen, {Kasper R{\o}mer} and Lukas Neumann and Raida, {Martin Kristian}",
year = "2013",
doi = "10.1016/j.fsi.2013.03.317",
language = "English",
volume = "34",
pages = "1739",
journal = "Fish and Shellfish Immunology",
issn = "1050-4648",
publisher = "Academic Press",
number = "6",
note = "null ; Conference date: 24-06-2013 Through 28-06-2013",

}

RIS

TY - ABST

T1 - DEVELOPMENT OF A YERSINIA RUCKERI O1 BIOTYPE 2 WATERBORNE CHALLENGE MODEL FOR FUTURE ERM VACCINE TESTING IN RAINBOW TROUT

AU - Kragelund Strøm, Helene

AU - Aalbæk, Bent

AU - Otani, Maki

AU - Villumsen, Kasper Rømer

AU - Neumann, Lukas

AU - Raida, Martin Kristian

PY - 2013

Y1 - 2013

N2 - Yersinia ruckeri (Y.r.) O1 biotype (bt) 2 causes outbreaks of Enteric Redmouth disease (ERM) in vaccinated, farmed rainbow trout around the world. Y.r. O1 bt 1 has been known since first described from the Hagerman Valley in Idaho in the 1950’s and outbreaks have now been controlled by vaccination for more than 35 years. Recent years have shown ERM outbreaks caused by Y.r. O1 bt 2 reported from ERM vaccinated farmed rainbow trout stocks in both Europe and the USA. It has been suggested that Y.r. O1 bt 2 is more virulent than bt 1. In order to test this hypothesis we have collected Y.r. O1 isolates from ERM outbreaks in Danish rainbow trout farms during 2011. Some of the isolates were obtained from vaccinated stocks, which subsequently developed ERM disease outbreaks. The Y.r. O1 isolates have been characterized and biotyped according to mobility and hydrolysis of Tween-80, and almost all isolates obtained in 2011 were double negative, which characterizes them as bt 2. Only one Y.r. O1 bt 1 strain was isolated, the rest of all the Y.r. O1 strains belonged to bt 2. Y.r. O1 bt 1 has been isolated from Danish rainbow trout farms for 30 years, but Y.r. O1 bt 2 has first been detected 12 years later and has caused many outbreaks of ERM which has led to an increase in the use of antibiotics. In order to determine the virulence of the newly isolated Y.r. O1 strains, experimental infections were carried out. The mortalities of the newly isolated strains were compared to well characterized isolates of both bt 1 and 2. In order to mimic a natural Y.r. infection, a bath infection model was applied. All Y.r. O1 isolates caused significant mortality compared to the un-infected control group. The Y.r. O1 isolates could be divided into two groups, regarding their virulence: A low virulence group causing less than 50 % mortality, and a high virulence group causing more than 50 % mortality. Interestingly, all tested bt 1 isolates grouped in the low virulence group together with a few bt 2 isolates. The highly virulent strains were exclusively Y.r. O1 bt 2 strains. The most virulent strain was obtained from a population of rainbow trout which had been immersion vaccinated with a commercial vaccine containing a bacterin of both Y.r. O1 bt 1 and 2 and received an oral booster vaccination 4 month later as recommended by the manufacturer. The characterization of this highly virulent strain of Y.r. O1 bt 2 has made it possible to develop a standardized bath challenge model which is needed in order to test and develop new experimental vaccines which are expected to induce immunity against Y.r. O1 bt 2.

AB - Yersinia ruckeri (Y.r.) O1 biotype (bt) 2 causes outbreaks of Enteric Redmouth disease (ERM) in vaccinated, farmed rainbow trout around the world. Y.r. O1 bt 1 has been known since first described from the Hagerman Valley in Idaho in the 1950’s and outbreaks have now been controlled by vaccination for more than 35 years. Recent years have shown ERM outbreaks caused by Y.r. O1 bt 2 reported from ERM vaccinated farmed rainbow trout stocks in both Europe and the USA. It has been suggested that Y.r. O1 bt 2 is more virulent than bt 1. In order to test this hypothesis we have collected Y.r. O1 isolates from ERM outbreaks in Danish rainbow trout farms during 2011. Some of the isolates were obtained from vaccinated stocks, which subsequently developed ERM disease outbreaks. The Y.r. O1 isolates have been characterized and biotyped according to mobility and hydrolysis of Tween-80, and almost all isolates obtained in 2011 were double negative, which characterizes them as bt 2. Only one Y.r. O1 bt 1 strain was isolated, the rest of all the Y.r. O1 strains belonged to bt 2. Y.r. O1 bt 1 has been isolated from Danish rainbow trout farms for 30 years, but Y.r. O1 bt 2 has first been detected 12 years later and has caused many outbreaks of ERM which has led to an increase in the use of antibiotics. In order to determine the virulence of the newly isolated Y.r. O1 strains, experimental infections were carried out. The mortalities of the newly isolated strains were compared to well characterized isolates of both bt 1 and 2. In order to mimic a natural Y.r. infection, a bath infection model was applied. All Y.r. O1 isolates caused significant mortality compared to the un-infected control group. The Y.r. O1 isolates could be divided into two groups, regarding their virulence: A low virulence group causing less than 50 % mortality, and a high virulence group causing more than 50 % mortality. Interestingly, all tested bt 1 isolates grouped in the low virulence group together with a few bt 2 isolates. The highly virulent strains were exclusively Y.r. O1 bt 2 strains. The most virulent strain was obtained from a population of rainbow trout which had been immersion vaccinated with a commercial vaccine containing a bacterin of both Y.r. O1 bt 1 and 2 and received an oral booster vaccination 4 month later as recommended by the manufacturer. The characterization of this highly virulent strain of Y.r. O1 bt 2 has made it possible to develop a standardized bath challenge model which is needed in order to test and develop new experimental vaccines which are expected to induce immunity against Y.r. O1 bt 2.

U2 - 10.1016/j.fsi.2013.03.317

DO - 10.1016/j.fsi.2013.03.317

M3 - Conference abstract in journal

VL - 34

SP - 1739

JO - Fish and Shellfish Immunology

JF - Fish and Shellfish Immunology

SN - 1050-4648

IS - 6

Y2 - 24 June 2013 through 28 June 2013

ER -

ID: 230849730